Search Within

Martin Henner Voss

Formats
  1. Meeting Abstract (150)
  2. Journal Article (122)
  3. Review (6)
  4. Editorial (5)
  5. Guidelines (2)
  6. Research Letter (2)
  7. Correspondence (1)
Groups
  1. Department of Medicine (288)
  2. Genitourinary Oncology Service (288)
  3. Solid Tumor Oncology Division (288)
  4. Human Oncology and Pathogenesis Program (104)
  5. Weinberg Fellows (104)
  6. Surgery (103)

More Groups

People
  1. Robert Motzer (176)
  2. Abraham Hakimi (95)
  3. Darren Feldman (80)
  4. Chung-Han Lee (75)
  5. Maria Carlo (65)
  6. Ritesh Kotecha (63)

More People

Years
  1. 2025 (6)
  2. 2024 (15)
  3. 2023 (21)
  4. 2022 (24)
  5. 2021 (30)
  6. 2020 (23)

More Years

Publications
  1. Journal of Clinical Oncology (116)
  2. Clinical Cancer Research (18)
  3. BJU International (15)
  4. Annals of Oncology (13)
  5. Journal for ImmunoTherapy of Cancer (12)
  6. Clinical Genitourinary Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (120)
  2. American Association for Cancer Research (26)
  3. Wiley Blackwell (22)
  4. Elsevier Inc. (21)
  5. Oxford University Press (18)
  6. Biomed Central Ltd (15)

More Publishers

Results (288)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment outcome with mTOR inhibitors for 65 cases of non-clear cell renal cell carcinoma: Association of long-term responses and oncogenomic events
    Meeting Abstract

    Voss, M. H.; Bastos, D. A.; Karlo, C.; Patil, S.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Molina, A. M.; Berger, M. F.; Hsieh, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • MicroRNA as novel blood-based biomarkers in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Jacobsen, A.; Mikkilineni, N.; Fiegoli, B.; Blass, S.; Grigoryev, Y.; Viale, A.; Socci, N. D.; Voss, M. H.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Association of mutations in chromatin modifiers with poor survival in clear cell renal cell carcinoma: Analysis of the Cancer Genome Atlas Project
    Meeting Abstract

    Hakimi, A. A.; Ostrovnaya, I.; Voss, M. H.; Motzer, R. J.; Russo, P.; Reuter, V. E.; Hsieh, J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • mTOR inhibitor therapy for metastatic sarcomatoid clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Bastos, D. A.; Voss, M. H.; Karlo, C.; Ajeti, A.; Patil, S.; Feldman, D. R.; Molina, A. M.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effective monotherapy despite intratumor heterogeneity: Clonal convergence within the PI3K pathway and sensitivity to mTOR inhibitors in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Chen, Y.; Pham, C. G.; Brannon, A. R.; Scott, S. N.; Takeda, S.; Liu, H.; Motzer, R. J.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Targeted therapy for renal cell carcinoma (RCC) with brain metastasis: Overall survival (OS) and safety
    Meeting Abstract

    Bastos, D. A.; Molina, A. M.; Jia, X.; Velasco, S.; Patil, S.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II randomized study of dalantercept in combination with axitinib compared to axitinib alone as second-line treatment in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Atkins, M. B.; Bhatt, R. S.; Voss, M. H.; Rini, B. I.; Jonasch, E.; Plimack, E. R.; Alter, R.; Barger, R.; Wilson, D.; McClure, T.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) in combination with sunitinib, pazopanib, or ipilimumab in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Amin, A.; Ernstoff, M. S.; Infante, J. R.; Heng, D. Y. C.; Rini, B. I.; Plimack, E. R.; McDermott, D. F.; Kollmannsberger, C. K.; Reaume, M. N.; Spratlin, J. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Furberg, H.; Zabor, E. C.; Jacobsen, A.; Schultz, N.; Ciriello, G.; Mikkilineni, N.; Fiegoli, B.; Kim, P. H.; Voss, M. H.; more...
    JNCI: Journal of the National Cancer Institute (2013)

    Fulltext@MSK | Save